GlaxoSmithKline (GSK) will raise its UK employees’ average salaries by around 4% in 2012. In the GSK annual report 2011, published on 12 March, the pharmaceutical firm also said it will raise average US employees’ salaries by 3% in 2012. The 4% pay rise will be reflected in the base salary of chief executive officer Andrew Witty and chief financial officer Simon Dingemans. The full benefits packages of Witty, Dingemans and other GSK executives include: a company car, life assurance, annual bonuses, matching shares under GSK’s share incentive plan, and a defined contribution (DC) pension scheme or legacy defined benefit (DB) pension scheme.
